Medicines Development for Global Health

Medicines Development for Global Health develops medicines and vaccines for neglected diseases. Our approach is to bring together the ideas of researchers with our development expertise and passion to develop new products that will be life changing for millions. We are a non-profit company - all funds in excess of expenses are devoted to this purpose. In June 2018 we received FDA approval of moxidectin, the first new treatment for River Blindness in more than 30 years. Next were turning our attention to seeing the benefit moxidectin might bring to other neglected tropical diseases and scabies. Read more at medicinesdevelopment.com....

Project management,medicine development,vaccine development,and clinical research

Medicines development for global health operates in the Biotechnology research industry.

Medicines development for global health's revenue is 11m - 100m

Medicines development for global health has 11 - 50 employees.